Jeffrey T. Mullaney - Concepedia

Author

Jeffrey T. Mullaney

Eli Lilly (United States)

Also Known As

J. T. MULLANEY, Jeffrey T Mullaney, Jeffrey T. Mullaney

Publications

427

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Arizona State University National Cancer Institute National Institutes of Health

About

Jeffrey T. Mullaney is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	245
2	Natural Sciences	8	8	222
3	Biochemistry	6	6	155
4	Chemical Biology	4	4	111
5	Chemistry	1	1	54

Jeffrey T. Mullaney

Publications

419

Citations

H-Index

Page 1

	Year	Citations
Diazonamide A and a Synthetic Structural Analog: Disruptive Effects on Mitosis and Cellular Microtubules and Analysis of Their Interactions with Tubulin Zobeida Cruz‐Monserrate, Hélène C. Vervoort, Ruoli Bai, Molecular Pharmacology	2003	116
Antineoplastic agents. 220. Synthesis of natural (-)-dolastatin 15 George R. Pettit, Delbert L. Herald, Sheo B. Singh, Journal of the American Chemical Society Medicinal ChemistryPharmaceutical ScienceChemical AnalysisDonut IconAntineoplastic Agents	1991	54
Non-Peptide RGD Surrogates Which Mimic a Gly-Asp β-Turn: Potent Antagonists of Platelet Glycoprotein IIb−IIIa Matthew J. Fisher, Bruce P. Gunn, Cathy S. Harms, Journal of Medicinal Chemistry Chemical BiologyType IiPlatelet Receptor Gpiib-iiiaMolecular PharmacologyThrombosis	1997	49
Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel–Dreyer chromatography Zobeida Cruz‐Monserrate, Jeffrey T. Mullaney, Patrick G. Harran, European Journal of Biochemistry	2003	47
1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors Kumiko Takeuchi, Jolie Bastian, Donetta S. Gifford‐Moore, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryThrombin InhibitorsBiochemistryBenzimidazole DerivativesMedicine	2000	35
The Dolastatins 20. A Convenient Synthetic Route to Dolastatin 15 George R. Pettit, Timothy J. Thornton, Jeffrey T. Mullaney, Tetrahedron Medicinal ChemistryBiosynthesisBioorganic ChemistryPharmaceutical ChemistryBiochemistry	1994	28
Privileged structure-based ligands for melanocortin receptors—tetrahydroquinolines, indoles, and aminotetralines Matthew J. Fisher, Ryan T. Backer, Saba Husain, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineReceptor (Biochemistry)Structure-based LigandsPharmacology	2005	24
Synthesis and structure–activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor Qing Shi, Paul L. Ornstein, Karin Briner, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryFunctional SelectivityMedicineNatural Sciences	2005	21
Privileged structure based ligands for melanocortin receptors—Substituted benzylic piperazine derivatives Matthew J. Fisher, Ryan T. Backer, Iván Collado, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyDerivativesPrivileged StructureFunctional SelectivityNatural Sciences	2005	13
Dihydroisoquinolone RGD mimics. Exploration of the aspartate isostere Matthew J. Fisher, Bruce P. Gunn, Cathy S. Harms, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesDihydroisoquinolone Rgd Mimics	1997	11

Page 1